Philips Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Receives FDA clearance to market its CVI-Q (color velocity imaging-quantification) technique, which the company claims is the first color flow ultrasound method "for directly quantifying the velocity and volume of blood flow in vessels." Using Philips' proprietary technology of "time domain signal processing," CVI-Q can provide measurements that improve physicians' precision in "diagnosing and determining the best treatment for vascular disorders," Philips says